XLV
ETFHealth Care Select Sector SPDR Fund
State Street · equity
Fund snapshot
The basics: what it costs, how big it is, and how it's moved lately.
-3.0% vs the broad market
Asset mix
62 positions across 2 asset typesTop holdings
Top 10 = 61% of the fund- 1LLYELI LILLY + CO14.75%
- 2JNJJOHNSON + JOHNSON10.75%
- 3ABBVABBVIE INC7.29%
- 4MRKMERCK + CO. INC.6.08%
- 5UNHUNITEDHEALTH GROUP INC6.04%
- 6TMOTHERMO FISHER SCIENTIFIC INC3.72%
- 7AMGNAMGEN INC3.52%
- 8ABTABBOTT LABORATORIES3.05%
- 9GILDGILEAD SCIENCES INC3.02%
- 10PFEPFIZER INC2.63%
Show all 62 positions
- 11VRTXVERTEX PHARMACEUTICALS INC2.23%
- 12BMYBRISTOL MYERS SQUIBB CO2.19%
- 13DHRDANAHER CORP2.15%
- 14ISRGINTUITIVE SURGICAL INC2.06%
- 15CVSCVS HEALTH CORP2.03%
- 16MDTMEDTRONIC PLC1.97%
- 17MCKMCKESSON CORP1.77%
- 18SYKSTRYKER CORP1.58%
- 19ELVELEVANCE HEALTH INC1.45%
- 20REGNREGENERON PHARMACEUTICALS1.34%
- 21CITHE CIGNA GROUP1.21%
- 22BSXBOSTON SCIENTIFIC CORP1.11%
- 23CORCENCORA INC1.05%
- 24HCAHCA HEALTHCARE INC1.04%
- 25CAHCARDINAL HEALTH INC0.93%
- 26EWEDWARDS LIFESCIENCES CORP0.83%
- 27MRNAMODERNA INC0.82%
- 28BDXBECTON DICKINSON AND CO0.81%
- 29HUMHUMANA INC0.80%
- 30IQVIQVIA HOLDINGS INC0.72%
- 31AAGILENT TECHNOLOGIES INC0.69%
- 32IDXXIDEXX LABORATORIES INC0.68%
- 33VEEVVEEVA SYSTEMS INC CLASS A0.66%
- 34WATWATERS CORP0.66%
- 35DXCMDEXCOM INC0.54%
- 36RMDRESMED INC0.53%
- 37BIIBBIOGEN INC0.52%
- 38ZTSZOETIS INC0.51%
- 39GEHCGE HEALTHCARE TECHNOLOGY0.50%
- 40CNCCENTENE CORP0.50%
- 41MTDMETTLER TOLEDO INTERNATIONAL0.44%
- 42LHLABCORP HOLDINGS INC0.44%
- 43DGXQUEST DIAGNOSTICS INC0.43%
- 44WSTWEST PHARMACEUTICAL SERVICES0.40%
- 45STESTERIS PLC0.36%
- 46INCYINCYTE CORP0.35%
- 47VTRSVIATRIS INC0.32%
- 48ZBHZIMMER BIOMET HOLDINGS INC0.30%
- 49RVTYREVVITY INC0.24%
- 50CRLCHARLES RIVER LABORATORIES0.22%
- 51SOLVSOLVENTUM CORP0.22%
- 52COOCOOPER COS INC/THE0.22%
- 53BAXBAXTER INTERNATIONAL INC0.21%
- 54TECHBIO TECHNE CORP0.19%
- 55ALGNALIGN TECHNOLOGY INC0.17%
- 56SSI US GOV MONEY MARKET CLASS0.17%
- 57PODDINSULET CORP0.16%
- 58UHSUNIVERSAL HEALTH SERVICES B0.15%
- 59HSICHENRY SCHEIN INC0.14%
- 60DVADAVITA INC0.10%
- 61IXCU6XAV HEALTH CARE SEP260.02%
- 622602335DCONTRA HOLOGIC INCORPO0.00%
Sector mix
More breakdowns
Company size
Country
Industry
The forces this fund tends to react to: broad economic shifts, leading sectors, and its biggest single names.
Concentration
The top 10 holdings make up 61% of the fund, and the single largest is 14.8%.
Show details
Concentration score (HHI): 562. Higher means more of the fund sits in fewer holdings.
Overlap with another fund
Pick a fund to see how many of the same holdings they share.
Overlap with the broad market
- ACWI5% shared · 50 names
- FIWGX0% shared · 14 names
- FCTDX3% shared · 58 names
- FCNTX7% shared · 23 names
- FXAIX8% shared · 58 names
- FBGRX4% shared · 12 names
- FBALX4% shared · 21 names
- FXNAX0% shared · 33 names
- IVV9% shared · 59 names
- QQQ3% shared · 8 names
- ROBO1% shared · 1 names
- SPY9% shared · 59 names
- VFIAX9% shared · 59 names
- VOO9% shared · 59 names
- VTI8% shared · 59 names
- VTSAX8% shared · 59 names
- XOVR1% shared · 2 names
- DIA13% shared · 4 names
Insight summary
A clear read on this fund, written from the data above.
The Health Care Select Sector SPDR Fund (XLV) is concentrated in the health care sector with 62 holdings, primarily in pharmaceuticals and biotechnology.
As of September 8, 2026, the fund has an expense ratio of 0.08%. It is concentrated, with 60.9% of its assets in the top 10 holdings. The fund mainly invests in common stocks, with a focus on U.S. companies. Major industry weights include pharmaceuticals at 37.2% and biotechnology at 19.1%. The data is current, with only 2 days of freshness.
What to watch: Key factors that could influence the fund include labor market conditions, interest rates, and economic growth.
Data freshness
How current the numbers on this page are.
Holdings as of 2026-09-08 (updated daily).
Holdings as of 2026-09-08 · Prices as of 2026-09-09 · 2 day(s) since last disclosure
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.